A cutting-edge preventive solution that transforms the health of your ponds with broad-spectrum action. Combats EHP and vibriosis, strengthens the immune system and supports sustained productivity throughout the entire culture cycle.
EHP and vibriosis control — broad-spectrum preventive formulation
Immune function — supports and strengthens the immune system
Digestive performance — improves nutrient absorption and growth
Healthy environments — consistent productivity in the culture cycle
Sustained Productivity
Vetra Stabil AQ minimizes disease outbreaks and boosts digestive performance for a more resilient shrimp. It delivers healthier pond environments and consistent results throughout the entire culture cycle.
A cutting-edge preventive solution that transforms pond health with broad-spectrum action.
Control and Prevention of EHP
"Combating EHP and vibriosis from the source."
2. Core Features
A Resilient, Healthy and Productive Shrimp Culture
Three core pillars define Vetra Stabil AQ — combating EHP and vibriosis, strengthening the immune system and sustaining productivity throughout the culture cycle.
Combats EHP and Vibriosis
Cutting-edge preventive solution
Transforms pond health
Broad-spectrum action
Strengthens the Immune System
Minimizes disease outbreaks
Boosts digestive performance
A more resilient shrimp
Sustained Productivity
Healthier pond environments
Consistent results
Throughout the entire culture cycle
EHP and Vibriosis Control
Broad-spectrum preventive health formulation
Immune Function
Supports and strengthens the shrimp's immune system
Digestive Performance
Improves nutrient absorption and growth
Healthy Environments
Consistent productivity during the culture cycle
3. Product Technology
CQNS™, BQNS™ & PQNS™
Carbon Quantum Nano Sphere, Botanical Quantum Nano Sphere and Phytosome Quantum Nano Sphere for the control of EHP and associated diseases. A quantum nano sphere technology product.
CQNS™ — Carbon Quantum Nano Sphere
Functional carbon nanostructures for cellular penetration and targeted action against pathogens.
BQNS™ — Botanical Quantum Nano Sphere
Plant-derived bioactive compounds with antimicrobial and anti-inflammatory properties.
PQNS™ — Phytosome Quantum Nano Sphere
Advanced delivery systems that improve the bioavailability and efficacy of the active compounds.
4. Disease Impact
Freedom from EHP and Stunted Growth
EHP damages the gut and causes nutrient malabsorption and stunted growth. EHP spores can remain viable up to 6 months and retain infectivity for more than a year under aqueous conditions.
1
Enterocytozoon hepatopenaei (EHP)
Damaged gut, nutrient malabsorption and stunted growth. Gut damage and desquamation due to Vibrio PIR toxins; weak immune system and establishment of vibriosis infection.
2
Associated Effects
White Muscle Disease (WMD), White Feces Syndrome (WFS) and Soft Shell Syndrome. Found in slow-growing shrimp and shrimp with mortality associated with WFS.
Reduced disease risk, optimal FCR, better production, successful harvest, indirect cost benefit and total confidence for the shrimp producer.
01
Risk Reduction — reduces the risk of EHP disease and vibriosis.
02
Optimal FCR — no stunted growth, which keeps the FCR high.
03
Better Production — improves growth for better production.
04
Successful Harvest — normal growth continues and allows a successful harvest with a good count.
05
Cost Benefit — the cost benefit is indirect, as the producer harvests as in a normal cycle.
06
Total Confidence — confidence of having no losses due to EHP and vibriosis infections.
6. Field Trials
Validated Across More Than 180 Acres
Field trials across more than 180 acres in 6 different locations on the south coast of India demonstrate the consistent performance of Vetra Stabil AQ.
Reduces WFS Risk
Reduces the risk of White Feces Syndrome and microsporidiosis.
Improvement in 5 Days
The best cases of ponds with stunted growth improve after five days of treatment and generate a good harvest.
Effective at Any Age
Effective at different animal ages (from day 7 to harvest).
Allows the producer to continue the culture with routine use of VETRA STABIL AQ.
7. Composition
Active Ingredients
A complete formulation built on nanoparticles, IgY antibodies (IQNS™), vitamins, chelated minerals, CQNS™-doped herbal actives, essential oils, organic acids, immunostimulants and more.
Nanoparticles
Silver, Copper, Selenium, Chromium, Calcium
Antibodies — IQNS™
IgY antibodies against Vibrio species (Immune Quantum Nano Sphere delivery)
Vitamins
A, D, E, K, B1, B2, B3, B5, B7, B9, B12, C
Chelated Minerals
Na, K, Ca, Mg, Mn, Fe, Co, Cr, B, Mo, Sn, Se, Ti, I, Ag, Cu, Ga, Cl
The feeding program is designed to cover both routine prevention and active treatment in case of outbreaks, adapting to the needs of the culture cycle.
Recommended Dose
Alternate feeding — prevention and treatment.
Prevention
2.5 g
per kg of feed
Prevention
Alternate feeding from day 5 (DOC) to 45 days DOC.
Treatment
5 g
per kg of feed
Treatment
Alternate feeding for two weeks.
Mode of Use
01 — Weigh the dose: weigh 2.5 g (prevention) or 5 g (treatment) according to the indicated program.
02 — Dissolve in water: dissolve 2.5 g in 50 ml of water, or 5 g in 100 ml of water, before mixing with 1 kg of feed.
03 — Mix with feed: mix the prepared solution with 1 kg of feed evenly.
04 — Dry and supply: dry for 30 minutes before supplying to the pond.
9. Trial Results — Description
Performance in an EHP-Infected Pond
Description: performance of VETRA STABIL AQ in an EHP-infected pond, compared across three pond conditions.
1
Pond 1
Negative control (uninfected pond).
2
Pond 2
Pond treated with VETRA STABIL AQ.
3
Pond 3
Positive control (untreated pond).
Parameter
Detail
Pond size
Approximately 1.5 acre
Age group
DOC 62
Study location
Ongole, AP
Time
April – May, 2018
Dose
5 grams/kg of feed for 14 days
10. Key Results & PCR
VETRA STABIL AQ Works in EHP-Infected Animals
Reduced size variability of animals in the control tray and improved PCR results following treatment with VETRA STABIL AQ.
Key Results
1. Untreated ponds, found positive for EHP at the same location, showed stunted growth.
2. The pond treated with VETRA STABIL AQ showed no size variability and disease-free growth.
3. Feed consumption of the treated group improved and recovered body weight.
4. Treated animals were found free of WFS.
PCR Results & Observation
Infected animals — PCR data: positive for EHP, with size variability and stunted growth observed in untreated ponds.
Treated animals — PCR data: improvement in PCR results, reduced size variability and recovery of normal growth after treatment with VETRA STABIL AQ.
11. Producer Feedback
Feedback from Producers Trialing VETRA STABIL AQ
Some comments from producers with VETRA STABIL AQ trials — consistently at 5 g/kg over 14 days.
Pond Symptom
Dosage
Days
General Response
Size variation, WFS
5 g/kg
14
Size variation problem resolved and increase in feed consumption, WFS cleared
WFS
5 g/kg
14
Works well, WFS cleared, satisfied, improvement in feed consumption
WFS cleared, no size variation, feed consumption improved
WFS
5 g/kg
14
WFS gone, feed consumption improved
WFS, soft shell
5 g/kg
14
Fully satisfied, WFS was cleared, soft shell controlled, consumption improved
Soft shell, WFS
5 g/kg
14
No soft shell, WFS cleared, consumption improved
WFS, soft shell
5 g/kg
14
WFS controlled, no soft shell, feed consumption improved
12. Field Report
Context, Impact and Analysis
A field report covering the context of the study, its economic impact and the profitability analysis for shrimp producers.
1. Context
Producers want to protect their ponds from EHP and vibriosis infections. Farm cost and income are evaluated with the prevention of losses due to stunted growth from microsporidiosis. The aim is to give the producer confidence to minimize the risk of financial losses from stunted growth and White Feces Syndrome.
2. Impact
The study provided the confidence that helped the producer evaluate the economic impacts of stunted-growth risk and losses that can be minimized with this therapy. It also identified the market opportunity that the product gives confidence for a disease-free culture to prevent vibriosis problems.
3. Analysis
Profitability is calculated based on how long the culture was maintained after preventive application of VETRA STABIL AQ. Harvest is the producer's sole decision; the research team calculated the risk assessment. Overall data show producers are free of stress from EHP, stunted growth and vibriosis.
Quantum Nanotechnology
"Disease-free culture and consistent productivity."
Vetra Stabil AQ
"Preventive formulation for the control of EHP and vibriosis, growth improvement and consistent productivity in shrimp culture."